Evidence map›Paper›PMID 27807339›Full record

ReviewThe American journal of case reports2016

Extensively Drug-Resistant Tuberculosis: Report and Literature Review on Two Cases Requiring Prolonged Treatment.

Martha Matos-Tocasca, Gabriel De la Cruz-Ku, Erick Auccacusi, Diego Fernandez-Salas, Tatiana García-Ahuanari, Bryan Valcarcel-Valdivia

Open access · hybridAbstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The American journal of case reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Martha Matos-Tocasca, Medical College of Peru, Lima, Peru.
Gabriel De la Cruz-Ku, Medical Student at Universidad Científica del Sur (UCSUR), Lima, Peru.
Erick Auccacusi, Medical Student at Universidad Científica del Sur (UCSUR), LimaLima-Perú, Peru.
Diego Fernandez-Salas, Medical Student at Universidad Científica del Sur (UCSUR), Lima, Peru.
Tatiana García-Ahuanari, Medical Student at Universidad Científica del Sur (UCSUR), Lima, Peru.
Bryan Valcarcel-Valdivia, Medical Student at Universidad Científica del Sur (UCSUR), Lima, Peru.
Universidad Científica del Sur · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Extensively drug-resistant tuberculosis (XDR-TB) is a global problem due to the high morbidity and mortality it causes. Peru is one of the countries with the highest numbers of cases of XDR-TB, which increase every year. CASE REPORT We present the case of two siblings who developed XDR-TB, underwent surgery twice, and were in individualized treatment for more than 6 years. Finally they achieved remission of symptoms, despite not having standardized treatment schemes during their diagnosis period. CONCLUSIONS Extensively drug-resistant tuberculosis can be cured with a treatment that involves both medical care and patient actions to achieve remission of the disease.

Indexed as

AdultAntitubercular AgentsDose-Response Relationship, DrugDrug Administration ScheduleExtensively Drug-Resistant TuberculosisFemaleFollow-Up StudiesHumansMaleMycobacterium tuberculosisTime FactorsTuberculin TestYoung AdultAntitubercular Agents

Identifiers

PMID27807339
PMCPMC5098927
OpenAlexW2547257078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.